New Risk Assessment Paradigm to Predict Screening Detection, Failures and False Alarms
New Risk Assessment Paradigm to Predict Screening Detection, Failures and False Alarms
批准号:
9982825
负责人:
KARLA M KERLIKOWSKE
金额:
$27.72万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-01 至 2022-05-31
关键词:
Advisory CommitteesAgeAmerican Cancer SocietyBenignBiopsyBreast Cancer DetectionBreast Cancer Risk FactorBreast Cancer Surveillance ConsortiumCancer BiologyCessation of lifeClinicalClinical/RadiologicCommunity PracticeConsensusDataDecision MakingDetectionDigital Breast TomosynthesisDigital MammographyDiseaseEarly DiagnosisEffectivenessEthnic OriginFailureFrequenciesGeneral PopulationGoalsGuidelinesHarm ReductionHealth PersonnelHeterogeneityHigh Risk WomanImageIncidenceIndividualInfrastructureLifeMalignant NeoplasmsMammographic screeningMammographyMasksModalityModelingMovementNoninfiltrating Intraductal CarcinomaOutcomeOutputPopulationPreventive serviceProviderRaceRadiation exposureRadiation-Induced CancerRecommendationRegimenResearch PersonnelRiskRisk AssessmentRisk EstimateRisk FactorsStatistical MethodsSubgroupSurveysTestingWomanWomen&aposs Healthadvanced diseaseagedbasebreast densitycancer invasivenesscare providersclinical practiceclinically actionablecomparative effectivenesscompare effectivenesscostdigitaldiscrete timeexperiencehigh riskimprovedinnovationlifetime riskmalignant breast neoplasmmodels and simulationmortalitynovelpersonalized decisionpredictive modelingpreferenceradiologistrisk prediction modelscreeningscreening guidelinessecondary outcometomosynthesistumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY – Project 1 The 2016 US Preventive Services Task Force and 2015 American Cancer Society guidelines call for reduced screening intensity and for providers to discuss with women their preferences for screening. This push for individualized decision-making has triggered substantial movement toward risk-based screening utilization that does not rely solely on a woman's age to determine when to start and stop screening or screening frequency. Yet, the explicit incorporation of risk assessment into screening guidelines for the general population is in its early stages. Risk prediction is a key aspect of risk-based screening; available models predict breast cancer risk overall, but do not take into account the heterogeneity of breast cancer biology or the ability of screening modalities to detect breast cancer. Project 1 aims to advance a new risk-based screening paradigm that identifies women's absolute cumulative risk of screening detection, failures, and false alarms while explicitly considering screening interval and modality used.
Aim 1) Using the existing and expanded Breast Cancer Surveillance Consortium (BCSC) infrastructure, project investigators will develop new risk prediction models to identify women at high risk of: 1) early-stage screen-detected cancer (stage I/IIa invasive cancer), 2) screening failure (interval invasive cancer or screen-detected stage IIb or higher), and 3) false alarms (false-positive tests and benign biopsies). Using BCSC data on over 1,000,000 women aged 40-79 years undergoing digital mammography or tomosynthesis, and over 13,000 invasive breast cancers identified, the project team will identify clinical and imaging factors associated with breast cancer risk that impact screening outcomes, generating six-year risk estimates for each screening outcome for annual, biennial, and triennial screening regimens.
Aim 2) The project team will identify actionable levels of clinically-meaningful risk of screening failure and false alarm, and associated long-term screening outcomes using women and clinician surveys and Delphi panels.
This proposal will answer: 1) Which women are at high risk of screening failures and require an alternative strategy to biennial mammography, and which women are at low risk and can be screened less often? 2) What risk levels of poor screening outcomes impact women and clinician preferences for screening strategies?
This project will provide evidence to guide women, health care providers, and policymakers on screening strategies based on short-term risk of screening failures and false alarms with the goal to improve early detection of aggressive tumors while minimizing harms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hawaii Pacific Islands Mammography Registry
-
批准号:10819068
-
项目类别:
-
资助金额:$5.55万
-
财政年份:2023
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Hawaii Pacific Islands Mammography Registry
-
批准号:10588112
-
项目类别:
-
资助金额:$68.89万
-
财政年份:2023
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Evaluation of novel tomosynthesis density measures in breast cancer risk prediction
-
批准号:10680241
-
项目类别:
-
资助金额:$70.18万
-
财政年份:2023
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
New Risk Assessment Paradigm to Predict Screening Detection, Failures and False Alarms
-
批准号:9279002
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2017
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Radiomic phenotypes of breast parenchyma and association with breast cancer risk and detection
-
批准号:9897495
-
项目类别:
-
资助金额:$63.26万
-
财政年份:2017
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Automated Density Measures for Estimating Breast Cancer Risk and Therapy Response
-
批准号:8601620
-
项目类别:
-
资助金额:$62.1万
-
财政年份:2013
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Automated Density Measures for Estimating Breast Cancer Risk and Therapy Response
-
批准号:8913697
-
项目类别:
-
资助金额:$63.59万
-
财政年份:2013
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Automated Density Measures for Estimating Breast Cancer Risk and Therapy Response
-
批准号:8693976
-
项目类别:
-
资助金额:$58.05万
-
财政年份:2013
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Automated Density Measures for Estimating Breast Cancer Risk and Therapy Response
-
批准号:9120340
-
项目类别:
-
资助金额:$76.72万
-
财政年份:2013
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Advancing Equitable Risk-based Breast Cancer Screening and Surveillance in Community Practice
-
批准号:10411220
-
项目类别:
-
资助金额:$381.82万
-
财政年份:2011
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Risk-Based Breast Cancer Screening in Community Settings
-
批准号:8543597
-
项目类别:
-
资助金额:$367.54万
-
财政年份:2011
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Project 1
-
批准号:10705576
-
项目类别:
-
资助金额:$15.22万
-
财政年份:2011
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Risk-based Breast Cancer Screening and Surveillance in Community Practice - Admin Supplement for P3
-
批准号:10164432
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2011
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Risk Assessment in Community Practice: Developing Better Models
-
批准号:8555529
-
项目类别:
-
资助金额:$55.78万
-
财政年份:2011
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Risk-Based Breast Cancer Screening in Community Settings
-
批准号:8734249
-
项目类别:
-
资助金额:$365.78万
-
财政年份:2011
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Risk-Based Breast Cancer Screening in Community Settings
-
批准号:8165617
-
项目类别:
-
资助金额:$398.89万
-
财政年份:2011
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Risk-Based Breast Cancer Screening in Community Settings
-
批准号:8338861
-
项目类别:
-
资助金额:$402.6万
-
财政年份:2011
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Risk-based Breast Cancer Screening and Surveillance in Community Practice
-
批准号:9982808
-
项目类别:
-
资助金额:$354.84万
-
财政年份:2011
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Project 1
-
批准号:10411221
-
项目类别:
-
资助金额:$14.95万
-
财政年份:2011
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
Advancing Equitable Risk-based Breast Cancer Screening and Surveillance in Community Practice
-
批准号:10705575
-
项目类别:
-
资助金额:$292.88万
-
财政年份:2011
-
负责人:KARLA M KERLIKOWSKE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: